Wei Jenny J, Hayward Elizabeth May, Leung Thomas H, Rosenbach Misha
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Dermatol Online J. 2019 Dec 15;25(12):13030/qt9rv5r4x6.
As wearable devices play an increasing role in the management of health and disease, adverse skin reactions to wearables have become more common. However, the management of allergic contact dermatitis is challenging and new treatment options more compatible with wearable devices are needed. In a 40-year-old woman with contact dermatitis to a continuous glucose monitoring device, topical clobetasol propionate 0.05% spray proved to be an effective treatment that was compatible with the application of adhesive wearables. This case demonstrates that spray formulations of topical steroids are a good option for the treatment of dermatitis under wearable devices such as continuous glucose monitors or ostomy appliance.
随着可穿戴设备在健康与疾病管理中发挥着越来越重要的作用，可穿戴设备引起的皮肤不良反应变得越发常见。然而，过敏性接触性皮炎的管理颇具挑战性，因此需要更适合可穿戴设备的新治疗方案。对于一名对连续血糖监测设备发生接触性皮炎的40岁女性，0.05%丙酸氯倍他索喷雾剂被证明是一种有效的治疗方法，且与粘贴式可穿戴设备的使用兼容。该病例表明，局部用类固醇喷雾剂是治疗诸如连续血糖监测仪或造口袋等可穿戴设备下皮炎的良好选择。
